Navigation Links
Syneron Medical Completes and Summarizes the Multi-site Clinical Study Agreed Upon with FDA for the UltraShape Contour I
Date:10/21/2013

s a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the U.S. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

For additional information, please visit http://www.syneron-candela.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncerta
'/>"/>

SOURCE Syneron Medical Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Global Medical Imaging Reagents Market 2012 - 2016: Worldwide Industry Latest Market Share, Investment Trends, Growth, Size, Trends, Strategy And Forecast Research Report
2. Cedars-Sinai Medical Center to Use Exosome Diagnostics Exosome RNA Biofluid Kits in Neo-Natal Setting and Cancer for Development of Personalized Medicine Diagnostics
3. Dr. Szczepan Baran Appointed to Board of Directors at Americans for Medical Progress
4. Global Medical Experts to Discuss Knowledge Translation for Integration of Complementary Therapies in Cancer Treatment at Vancouver, BC Conference
5. Global 3D Medical Imaging Industry
6. Portland Medical Marijuana Clinic - The Aurora Clinic - Now Offering Complimentary Telephone Consultations for Washington and Oregon Medical Marijuana Cards
7. V. Suzanne Klimberg, M.D. Appointed Medical Director of Ascendant Diagnostics™
8. Miami’s Preferred Cord Blood Laboratory, GeneCell International, Partakes in North Shore Medical Center and Hialeah Hospital’s OB/GYN Symposium
9. Young scientists receive NSBRI space biomedical research fellowships
10. Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Invention
11. VIVEX BIOMEDICAL Successfully Completes $7.6 Million Round of Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... ... will provide new insights on mechanics of fecal microbiota transplantation in C. difficile ... study the microbiome of patients undergoing fecal microbiota transplantation (FMT) as a treatment ...
(Date:6/30/2015)... ... June 30, 2015 , ... Noblis, Inc., a leading ... a paper published this week in the scientific journal Viruses ( http://www.mdpi.com/1999-4915/7/6/2763 ), ... currently used to detect the Ebola virus. Noblis worked with the Department of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Matrix Marketing Group, LLC , a ... Gem Swartz to head up its account management department as vice president of client ... Amanda bring senior account management and delivery expertise to the growing Matrix Marketing Group ...
(Date:6/30/2015)... , June 30, 2015  Custom Computer Specialists, Inc. ... that they are silver sponsors of the Primary Care ... sponsor, Custom is lending their support of PCDC,s mission ... Since its founding in 1993, PCDC has ... care area.  PCDC has financed over 100 completed primary ...
Breaking Biology Technology:uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 2Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 3Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 4Matrix Marketing Group Expands Client Services Team 2Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2
... 28, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... extension study (MOR-100) in which patients have continued treatment on ... the initial Phase 1/2 study of GALNS (MOR-002) were continued ... MOR-100 study, patients were treated at a 2.0 mg/kg/week dose ...
... AllograftPossibilities.org has rapidly grown into the premier ... on the web. Although it has the same life-saving ... still lesser understood by the general public. The nonprofit ... of bone and soft-tissue allografts for use in surgical ...
... SAN DIEGO, July 28, 2011 Verenium Corporation (NASDAQ: ... and commercialization of high-performance industrial enzyme solutions, today announced ... of its 5.5% Notes and approximately $3 million in ... are very pleased to have taken another important step ...
Cached Biology Technology:BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 2BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 3BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 4BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 5BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 6AllograftPossibilities.org Meets Unmet Need for Consumer-Oriented Information on Tissue Donation, Transplantation on the Internet 2AllograftPossibilities.org Meets Unmet Need for Consumer-Oriented Information on Tissue Donation, Transplantation on the Internet 3Verenium Announces Debt Repurchase 2Verenium Announces Debt Repurchase 3
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/17/2015)... , June 17, 2015 QIAGEN ... launched new Investigator ® STR assay kits for analysis ... United States . The new genetic fingerprint kits provide ... (short tandem repeats or STRs) for DNA matching. They incorporate ... of DNA in each sample, a novel QIAGEN technology that ...
(Date:6/16/2015)... 16, 2015  With the increasing number and severity ... top concern. The recent compromise of Federal employee ... strong authentication within government agencies. HYPR Corp. ... password (OTP) authenticator, has been submitted for testing and ... 3 validation for tamper proofing. The ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... (CHICAGO - Sept. 30, 2009) U.S. Environmental Protection Agency,s ... of a dioxin exposure study conducted by the University ... the study was conducted well and provided useful, scientifically ... to help EPA fully evaluate human exposure to levels ...
... KINSTON, N.C., Oct. 1 Spatial Integrated Systems, ... integration of solutions incorporating next-generation digital 3D data ... United States patent application has been published for ... 3-dimensional image rendering" under Publication No. US2009/0169095A1. , ...
... University of Warwick and Rothamsted Research have been awarded ... (BBSRC) in partnership with Syngenta, to research the decline ... have fallen by 10-15% over the last 2 years; ... 30% for 2008. Since the declines were first reported ...
Cached Biology News:EPA reviews Univ. of Michigan dioxin study 2Spatial Integrated Systems, Inc. Files Patent Application 2£1 million award to address honeybee decline 2£1 million award to address honeybee decline 3